Comparison of low dose and standard dose adrenocorticotropin stimulation tests in healthy Nigerians.

Abstract

Hypothalamo-pituitary-adrenal (HPA) axis dysfunction is a potentially life-threatening condition. It is of paramount importance that safe, reliable diagnostic tests be available to identify patients at risk for adrenal insufficiency. The 250μg Adrenocorticotropic hormone (ACTH) stimulation test is commonly used to assess adrenocortical function. The 250μg dose is supraphysiological, therefore several investigators, over the years, have used 1μg ACTH stimulation test to assess adrenocortical function.The aim of the study was to compare the response of healthy adult Nigerian subjects to the 250μg and 1μg ACTH tests.Ten healthy subjects, five males and five females, aged between 20-60 years, (mean, 38.7 years) participated in this study. They all had normal medical histories and physical examinations, were nonsmokers, and had never received any type of glucocorticoid therapy. Serum chemistries, full blood counts, erythrocyte sedimentation rate, were all within normal limits. Both low dose ACTH test and standard dose ACTH test were performed on the 10 subjects in a randomized order on different days.There was no statistically significant difference in mean serum cortisol levels between the two test doses at 30 minutes (928.4 vs 929.8nmol/L). There was a strong correlation between 30-minute cortisol responses to 1μg and 250μg ACTH stimulation tests, r=0.999; p<0.001.In agreement with other published data, our study confirms that 1μg ACTH stimulates adrenocortical secretion in normal subjects in the period 30 minutes post injection comparable to 250μg ACTH testing.

Keywords: Cortisol; adrenocorticotropic hormone (ACTH); hypothalamo-pituitary-adrenal (HPA); low dose ACTH Nigerians.

Résumé
Le dysfonctionnement de l’axe hypothalamo hypophyseale est potentiellement une condition dangereuse pour la vie. Il est d’une importance capital que les diagnostiques tests justes et fiables soient disponibles pour identifier les patients a risque d’insuffisance adrenale. Le test de stimulation de l’hormone adrenocorticotropique est généralement utilisé pour déterminer les fonctions adrenocorticales. La dose de250μg est supra physiologique, cependant plusieurs investigateurs, pendant des années, ont utilises la dose de1μg d’ACTH pour déterminer la fonction adrenocorticale. Le but de l’étude était de comparer la réaction des sujets Nigérians adultes et bien portent aux tests de 250 μg et 1 μg ACTH. Dix sujets bien portants, cinq males et cinq femelles âgés entre 20-60 ans,(moyenne, 38.7 ans) ont participe a cette étude, ils avaient tous un passé médical normal et des examens physiques normales, ils étaient non fumeurs et n’avaient jamais reçu un quelconque type de thérapie glucocorticoïde. Le sérum chimique, le taux de sang, le taux de sédimentation de l’érythrocyte étaient tous dans les limites normales. La faible dose du test ACTH et la dose standard du test ACTH étaient faites sur les 10 sujets des jours différents. Il y’avait statistiquement pas de différence significative sur la moyenne du niveau de sérum cortisol entre les deux doses tests a 30 minutes (928.4 Vs 929.8 nmol/L). il y’avait une forte corrélation entre la réaction a 30 minutes de cortisol au test de stimulation ACTH 1 μg et 250 μg, R=0.999 ; p=0.001. En accord avec les données publies, notre étude confirme que 1 μg d’ACTH de sécrétion stimule d’adrenocorticale sur les sujets normaux dans une période de 30 minutes après l’injection est comparable a 250 μg d’ACTH testées.

Correspondence: Dr. I.A. Odeniyi, Department of Medicine, Lagos University Teaching Hospital, PMB 12003, Surulere, Lagos, Nigeria. E-mail: ifeode@yahoo.com

pdf (inglese)

Riferimenti bibliografici

Grinspoon SK and Biller BMK: Clinical review 62: Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab 1994; 79:923-931.

Dickstein G, Shechner C, Nicholson WE, et al. Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test. J Clin Endocrinol Metab. 1991; 72(4): 773-778.

Crowley S, Hindmarsh PC, Honour JW and Brook CG. Reproducibility of the cortisol response to stimulation with a low dose of ACTH(1-24): The effect of basal cortisol levels and comparison of low-dose with high-dose secretory dynamics. J Endocrinol 1993; 136:167.

Daidoh H, Morita H, Mune T, et al. Responses of plasma adrenocortical steroids to low dose ACTH in normal subjects. Clinical Endocrinology 1995; 43: 311–315.

Tordjman K, Jaffe A, Grazas N, Apter C and Stern N. The role of the low dose (1 µg) adrenocorticotropin test in the evaluation of patients with pituitary diseases. J Clin Endocrinol Metab. 1995; 80:1301–1305.

Broide J, Soferman R, Kivity S, et al. Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids. J Clin Endocrinol Metab. 1995; 80:1243–1246.

Dickstein G, Spigel D, Arad E and Shechner C. One µg is the lowest ACTH dose to cause maximal cortisol response, unrelated to weight. There is no diurnal variation of cortisol response to submaximal ACTH stimulation. Eur J Endocrinol 1997; 137:172-175.

Thaler LM and Blevins LS Jr: The low dose (1-µg) adrenocorticotropin stimulation test in the evaluation of patients with suspected central adrenal insufficiency. J Clin Endocrinol Metab 1998; 83:2726-2729.

Oelkers W: Adrenal Insufficiency. N. Engl. J Med 1996; 335:1206-1212.

Kelestimur F, Goktas Z, Gulmes I, et al: Low dose (1 microgram) adrenocorticotrophin stimulation test in the evalution of hypothalamo-pituitary-adrenal axis in patients with active tuberculosis. J Endocrinol Invest. 2000; 23:235-239.

Rasmuson S, Olsson T and Hagg E: A low dose ACTH test to assess the function of HPA-Axis. Clin Endocrinol 1996;44:151-156.

Adadevoh BK. Adrenocortical function in Nigerians. The W Afr Med J 1970; 19:25-26.

Adadevoh BK. Endocrine patterns in the African. Trop Geogr.Med 1970; 22:125-141.

Miller WL and Chrousos GP. The adrenal cortex. In: Felig P, Frohman LA eds: Endocrinology and Metabolism. 4th edn USA: McGraw-Hill.2001:387-524.

Streeten DHP, Anderson GH, Dalakos TG, et al. Normal and abnormal function of the hypothalamic-pituitary-adrenocortical system in man. Endocr Rev. 1984; 5:371–394.

Fiad TM, Kirby JM, Cunningham SK and McKenna TJ. The overnight single-dose metyrapone test is a single and reliable index of the hypothalamicpituitary-adrenal axis. Clin Endocrinol (Oxf). 1994; 40:603– 609.

Liddle GW, Estep HL, Kendall JW, Williams WC and Townes AW. Clinical application of a new test of pituitary reserve. J Clin Endocrinol Metab. 1959; 19:875– 894.

Hartzband PI, Van Herle AJ, Sorger L and Cope D. Assessment of hypothalamic-pituitary-adrenal (HPA) axis dysfunction: comparison of ACTH stimulation, insulin-hypoglycemia and metyrapone. J Endocrinol Invest. 1988; 11:769 –776.

Cunningham SK, Moore A and McKenna TJ. Normal cortisol response to corticotropin in patients with secondary adrenal failure. Arch Intern Med. 1983; 143:2276 –2279.

Streeten DHP, Anderson GH and Bonaventura MM. The potential for serious consequences from misinterpreting normal responses to the rapid adrenocorticotropin test. J Clin Endocrinol Metab. 1996; 81:285–290.

Trainer PJ and Rees LH: The diagnosis of adrenal failure. In: Boloux PM, Rees LH, eds. Diagnostic test in endocrinology and diabetes 1st ed. London: Chapman & Hall Medical 1994: 252–260.

Tsigos C, Kamilaris TC and Chrousos GP: Adrenal diseases. In: Moore TW, Eastman RC, eds. Diagnostic endocrinology, 1st ed. St. Louis: Mosby; 1998:125–156.

Crowley S, Hindmarsh PC, Holownia P, Honour JW and Brook CGD: The use of low doses of ACTH in the investigation of adrenal function in man. Journal of Endocrinology 1991; 130: 475–479.

Weintrob N, Sprecher E, Josefberg Z, et al. Standard and low-dose short adrenocorticotropin test compared with insulin-induced hypoglycemia for the assessment of the hypothalamic-pituitary-adrenal axis in children with idiopathic multiple pituitary hormone deficiencies. J Clin Endocrinol Metab. 1998; 83:88 –92.

Murphy H, Livesey J, Espiner EA and Donald RA. The low dose ACTH test–a further word of caution [Letter]. J Clin Endocrinol Metab. 1998; 83:712–713.

Nye EJ, Grice JE, Hockings GI, et al. Comparison of Adrenocorticotropin (ACTH) Stimulation Tests and Insulin Hypoglycemia in Normal Humans: Low Dose, Standard High Dose, and 8-Hour ACTH-(1–24) Infusion Tests. J Clin Endocrinol Metab 1999; 84: 3648–3655.

Dickstein G, Arad E and Shechner C. Low-dose ACTH stimulation test. Endocrinologist. 1997; 7:285–293.

Abdu TAM, Elhadd TA, Neary R and Clayton RN. Comparison of the low dose short Synacthen test (1mcg), the conventional dose short Synacthen test (250mcg), and the insulin tolerance test for assessment of the hypothalamopituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab. 1999; 84:838–843.

Mayenknecht J, Diederich S, Bahr V, Plokinger U and Oelkers W. Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease. J Clin Endocrinol Metab. 1998; 83:1558 –1562.